Benitec Biopharma (BNTC) Operating Income: 2019-2025
Historic Operating Income for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to -$9.8 million.
- Benitec Biopharma's Operating Income fell 77.25% to -$9.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$41.8 million, marking a year-over-year decrease of 85.70%. This contributed to the annual value of -$41.8 million for FY2025, which is 85.70% down from last year.
- Latest data reveals that Benitec Biopharma reported Operating Income of -$9.8 million as of Q2 2025, which was up 35.87% from -$15.3 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Operating Income registered a high of -$3.5 million during Q1 2022, and its lowest value of -$15.3 million during Q1 2025.
- Over the past 3 years, Benitec Biopharma's median Operating Income value was -$5.8 million (recorded in 2023), while the average stood at -$7.3 million.
- Its Operating Income has fluctuated over the past 5 years, first climbed by 8.78% in 2022, then plummeted by 270.32% in 2025.
- Benitec Biopharma's Operating Income (Quarterly) stood at -$4.8 million in 2021, then fell by 16.03% to -$5.6 million in 2022, then decreased by 23.48% to -$6.9 million in 2023, then plummeted by 55.98% to -$10.8 million in 2024, then crashed by 77.25% to -$9.8 million in 2025.
- Its last three reported values are -$9.8 million in Q2 2025, -$15.3 million for Q1 2025, and -$10.8 million during Q4 2024.